⌘K

Login Start Free

Home/Filings/4/0001012975-25-000718

4//SEC Filing

Mates Sharon 4

Accession 0001012975-25-000718

CIK 0001808898other

View on SEC.gov Company Profile

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 7:50 PM ET

Size

5.1 KB

Accession

0001012975-25-000718

Insider Transaction Report

Form 4

Period: 2025-11-05

Benitec Biopharma Inc.BNTC

Director

Transactions

Award
Options (right to buy)
2025-11-05+28,517→ 28,517 total
Exercise: $15.78Exp: 2035-11-05→ Common Stock (28,517 underlying)

Footnotes (1)

[F1]The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother

Related Parties

1

filerCIK 0001585699

Filing Metadata

Form type: 4
Filed: Nov 6, 7:00 PM ET
Accepted: Nov 7, 7:50 PM ET
Size: 5.1 KB

View on SEC.gov